To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

NANot yet recruitingINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 17, 2027

Study Completion Date

January 17, 2028

Conditions

Coronary Artery DiseaseCoronary Artery StenosisPercutaneous Coronary Interventionde Novo Lesions in Native Coronary Arteries

Interventions

DEVICE

Coronary Stent

RisoR Crest Everolimus Eluting Coronary Stent System

All Listed Sponsors

lead

Poly Medicure Limited

INDUSTRY

NCT07098195 - To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System | Biotech Hunter | Biotech Hunter